NO833717L - Fremstilling av modifiserte stammer av bovin-diarrevirus og vaksine inneholdende dem - Google Patents

Fremstilling av modifiserte stammer av bovin-diarrevirus og vaksine inneholdende dem

Info

Publication number
NO833717L
NO833717L NO833717A NO833717A NO833717L NO 833717 L NO833717 L NO 833717L NO 833717 A NO833717 A NO 833717A NO 833717 A NO833717 A NO 833717A NO 833717 L NO833717 L NO 833717L
Authority
NO
Norway
Prior art keywords
virus
bvd
diarvirus
bovin
preparation
Prior art date
Application number
NO833717A
Other languages
English (en)
Other versions
NO166953C (no
NO166953B (no
Inventor
Jean-Claude Delgoffe
Michele Lobmann
Nathan Zygraich
Original Assignee
Smith Kline Rit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline Rit filed Critical Smith Kline Rit
Publication of NO833717L publication Critical patent/NO833717L/no
Publication of NO166953B publication Critical patent/NO166953B/no
Publication of NO166953C publication Critical patent/NO166953C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18511Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24311Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24311Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24361Methods of inactivation or attenuation
    • C12N2770/24363Methods of inactivation or attenuation by chemical treatment
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/813Viral vaccine for bovine species, e.g. cattle
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/821Drug, bio-affecting and body treating compositions involving temperature-sensitive mutant virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
NO833717A 1982-10-13 1983-10-12 Fremgangsmaate for fremstilling av en modifisert temperatursensitiv stamme av kvegdiarevirus. NO166953C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/434,155 US4618493A (en) 1982-10-13 1982-10-13 Temperature sensitive strains of bovine viral diarrhoea virus, preparation thereof and vaccines containing them

Publications (3)

Publication Number Publication Date
NO833717L true NO833717L (no) 1984-04-16
NO166953B NO166953B (no) 1991-06-10
NO166953C NO166953C (no) 1991-09-18

Family

ID=23723042

Family Applications (1)

Application Number Title Priority Date Filing Date
NO833717A NO166953C (no) 1982-10-13 1983-10-12 Fremgangsmaate for fremstilling av en modifisert temperatursensitiv stamme av kvegdiarevirus.

Country Status (16)

Country Link
US (1) US4618493A (no)
EP (1) EP0106831B1 (no)
JP (3) JPS5989631A (no)
AT (1) ATE48948T1 (no)
AU (1) AU572050B2 (no)
CA (1) CA1216234A (no)
DE (1) DE3381005D1 (no)
DK (1) DK170061B1 (no)
ES (2) ES8504929A1 (no)
FI (1) FI82264C (no)
GR (1) GR78966B (no)
IE (1) IE56438B1 (no)
NO (1) NO166953C (no)
NZ (1) NZ205491A (no)
PT (1) PT77454B (no)
ZA (1) ZA837573B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291228B1 (en) 1988-08-03 2001-09-18 Vericore Limited Vaccine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3052606A (en) * 1958-08-30 1962-09-04 Behringwerke Ag Viral mutation with nitrites
US3293129A (en) * 1962-02-01 1966-12-20 Cornell Res Foundation Inc Immunization of cattle against virus diarrhea virus
US3629413A (en) * 1970-02-04 1971-12-21 Univ Southern Illinois Polyvalent bovine vaccines and methods of making and using same
US3907986A (en) * 1972-12-18 1975-09-23 Rit Rech Ind Therapeut Live attenuated infectious bovine rhinotracheitis virus vaccines and preparation thereof
GB1390467A (en) * 1973-03-30 1975-04-16 Rit Rech Ind Therapeut Vaccination method using temperature sensitive virus mutants
US3927208A (en) * 1973-05-14 1975-12-16 Rit Rech Ind Therapeut Live bovine adenovirus vaccines, preparation thereof and method of vaccination using them
US3962424A (en) * 1974-01-31 1976-06-08 Recherche Et Industrie Therapeutiques (R.I.T.) Live brovine adenovirus vaccines, preparation thereof and method of vaccination using them
US4053583A (en) * 1976-03-01 1977-10-11 Smithkline Corporation Live newcastle disease virus vaccines
JPS5817084B2 (ja) * 1978-08-25 1983-04-05 新明和工業株式会社 塵芥押込処理装置の操作装置

Also Published As

Publication number Publication date
JPS5989631A (ja) 1984-05-23
AU572050B2 (en) 1988-04-28
ES526382A0 (es) 1985-10-01
NO166953C (no) 1991-09-18
ATE48948T1 (de) 1990-01-15
PT77454B (en) 1986-02-26
US4618493A (en) 1986-10-21
JPH0773493B2 (ja) 1995-08-09
JPH05192139A (ja) 1993-08-03
PT77454A (en) 1983-11-01
EP0106831A2 (fr) 1984-04-25
CA1216234A (en) 1987-01-06
ES8600058A1 (es) 1985-10-01
DK170061B1 (da) 1995-05-15
DK472083D0 (da) 1983-10-13
AU1852983A (en) 1984-04-19
JPH05176764A (ja) 1993-07-20
ZA837573B (en) 1984-08-29
IE56438B1 (en) 1991-07-31
DE3381005D1 (de) 1990-02-01
IE832400L (en) 1984-04-13
GR78966B (no) 1984-10-02
FI82264B (fi) 1990-10-31
FI82264C (fi) 1991-02-11
NZ205491A (en) 1989-07-27
FI833717A0 (fi) 1983-10-12
NO166953B (no) 1991-06-10
EP0106831A3 (en) 1986-01-22
ES526380A0 (es) 1985-04-16
DK472083A (da) 1984-04-14
FI833717A (fi) 1984-04-14
ES8504929A1 (es) 1985-04-16
EP0106831B1 (fr) 1989-12-27
JPH0463862B2 (no) 1992-10-13
JPH0773494B2 (ja) 1995-08-09

Similar Documents

Publication Publication Date Title
NO912226L (no) Pneumolysinmutanter og pneumokokkvaksiner fremstilt derav.
Zygraich et al. In vivo and in vitro properties of a temperature sensitive mutant of infectious bovine rhinotracheitis virus
US3927208A (en) Live bovine adenovirus vaccines, preparation thereof and method of vaccination using them
NO833717L (no) Fremstilling av modifiserte stammer av bovin-diarrevirus og vaksine inneholdende dem
GB1413614A (en) Virus production
Oxford The growth of rubella virus in small laboratory animals
DE1792256B2 (de) Oral applizierbare, polyvalente Impfstoffe gegen lokale Darminfektionen
KR840001515B1 (ko) 백신의 제조방법
Fribourg-Blanc et al. Congenital Syphilis
JPS5522641A (en) Antiallergic agent
RU92006181A (ru) Аттенуированный холодоадаптированный штамм вируса гриппа в/ссср/60/69 для получения живой интраназальной гриппозной вакцины
Levenbook et al. Sensitization induced in guinea pigs with beta-propriolactone-treated serum albumin: experimental evidence for the cause of allergic reactions in humans receiving human diploid cell rabies vaccines
Takeda et al. The effects of a trichothecene, T-2 toxin, on growth of Japanese encephalitis virus in chick embryo cells and mice.
GB2001995A (en) An immunostimulant, a process for preparing it, and compositions containing it
Zhdanov et al. Control of Infectious Diseases in the Seven-Year Plan
Wasinski et al. Effect of antibiotics on the immune response of pigs against erysipelas suum vaccinated against swine fever, erysipelas and colibacillosis.
Felfe et al. Trends in production of foot-and-mouth disease vaccine.
Barber Antigenic structure of Salmonella paratyphi A grown on artificial media.
GB871838A (en) Purification of poliomyelitis virus
SE8104690L (sv) Vaccin mot kikhosta

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN APRIL 2003